- Home
- CSQ vs CNTA Comparison
CSQ vs CNTA Comparison
Compare CSQ & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$27.70
Company Overview
Basic Information| Metric | CSQ | CNTA |
|---|---|---|
| Founded | 2003 | 2020 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.5B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | CSQ | CNTA |
|---|---|---|
| Price | $16.46 | $27.70 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $40.89 |
| AVG Volume (30 Days) | 317.1K | ★ 1.4M |
| Earning Date | 01-01-0001 | 05-13-2026 |
| Dividend Yield | ★ 7.53% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.11 | $9.60 |
| 52 Week High | $19.83 | $30.58 |
Technical Indicators
Market Signals| Indicator | CSQ | CNTA |
|---|---|---|
| Relative Strength Index (RSI) | 21.93 | 52.45 |
| Support Level | N/A | $24.62 |
| Resistance Level | $19.52 | $30.29 |
| Average True Range (ATR) | 0.36 | 1.73 |
| MACD | -0.11 | -0.02 |
| Stochastic Oscillator | 2.17 | 47.44 |
Price Performance
Historical Comparison CSQ
CNTA
About CSQ Calamos Strategic Total Return
Calamos Strategic Total Return Fund is a diversified, closed-end management investment company. The fund's objective is to provide total return through a combination of capital appreciation and current income. Its investment portfolio comprises equities, convertible securities, and high-yield corporate bonds.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.